CCRM Australia proposes a more pro-active intellectual property policy as an option to unlock Australia’s best-protected treasure trove. CCRM Australia was one of many organisations that submitted a
Regenerative medicine is no longer an obscure concept. With major translational milestones in recent years, from the rollout of CAR-T therapies to the emerging commercialisation of tissue engineering
Author: Mahmuda Khatun Editor: Dr Chih Wei Teng The exponential growth of regenerative medicine (RM) has attracted many venture businesses and companies seeking to discover newer therapeutic interventions
The Centre for Commercialization of Regenerative Medicine (CCRM) Australia again partners with local and international venture capital firms to hold a second National Regenerative Medicine SuperPitch. The SuperPitch
Authors: Bhavi Kadakia, Dharvi Patel, Harmanpreet Harmanpreet, Mahmuda Khatun Edited by: Dr Chih Wei Teng CCRM Australia offers various programs designed to support the development of the Australian
Author: Dr Chih Wei Teng The world waits in bated breath for a COVID-19 vaccine as numerous countries remain locked down in varying degrees. At the time of
Author: Ali Ranjbaran, Editor: Dr Chih Wei Teng Progress in medical science has always been driven by the need to overcome challenges and new threats to public health.
The CCRM Australia team is modifying how we work and how we engage with those around us due to the evolving COVID-19 situation. We are well prepared to
